-
Researchers Find Clue to Why Mesothelioma Tumors Fail to Respond to Immune Activity
Researchers from the Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, in Reggio Emilia, Italy, have published the results of a recent study on why some mesothelioma patients don’t respond well to immunotherapy treatment. The scientists studied 89 mesothelioma samples and discovered that in patients whose cells showed deletion of a gene called CDKN2A, their tumors’
-
Combined Therapy Clinical Trial Seeks Mesothelioma Patients
One of medicine’s most enduring challenges is the quest for a more effective treatment for malignant mesothelioma, and Baylor College of Medicine and Duke University have built a reputation for their collaborative work in pursuit of that goal. Scientists from the esteemed institutions have recently announced another groundbreaking clinical trial that will gauge the impact
-
Mesothelioma Drug Granted Fast Track Designation
Patients diagnosed with pleural mesothelioma have limited treatment options, but the FDA’s recent approval of fast-track designation for an investigational small molecule therapeutic called VT3989 offers reason for hope. The new treatment, which is specifically designed to treat unresectable malignant pleural or nonpleural mesothelioma that has progressed after prior immune checkpoint inhibitor therapy and platinum-based chemotherapy,
-
Jury Orders Johnson & Johnson to Pay $966 Million to Mesothelioma Victim’s Family
Mae Moore was 88 years old when she died of malignant mesothelioma. The wife of a pastor, Moore had used Johnson & Johnson’s Baby Powder throughout her life and blamed asbestos in the product for her fatal illness. This week, a Los Angeles jury ordered the consumer giant to pay her family almost $1 billion
-
Pennsylvania Supreme Court to Consider Mesothelioma Victims’ Argument in Dravo Shipyard Case
Today, the Pennsylvania Supreme Court will hear arguments in a case involving mesothelioma victims and a shipyard’s parent company. The victims want to pursue asbestos exposure claims against Carmeuse Lime Inc., parent company of dissolved shipyard operator Dravo LLC, but a lower court dismissed the case based on statutory time limitations. A split appellate panel
-
Study Shows Loose-Fill Asbestos Increases Mesothelioma Risk Copy
A study conducted by researchers in Australia has highlighted the increased risk of a malignant mesothelioma diagnosis for those living in a home insulated with loose-fill asbestos insulation. Though the study was conducted in Australia, its conclusions carry great impact in both the United States and Canada, where asbestos-contaminated insulation was used in millions of
-
Mesothelioma Plaintiff’s Claim Against General Electric Moves Forward
Dennis and Susan Payne filed a mesothelioma lawsuit against General Electric after he was diagnosed with the rare, fatal form of cancer. Their claim referenced Mr. Payne’s years with the California Maritime Academy, when he worked aboard a training ship and was exposed to asbestos in a General Electric turbine. Though the company requested that
-
Honeywell Divestiture Shifts Mesothelioma Liabilities
Honeywell International announced a $1.69 billion transaction that eliminates its financial responsibility for payments to mesothelioma victims. The deal, which involved contributions from both Honeywell and corporate liability acquisition platform Delticus, permanently shifts liabilities for legacy asbestos claims that Honeywell has faced ever since it acquired North American Refractories Company (NARCO) and Bendix Friction Materials.
-
Mesothelioma Plaintiff Wins Ruling Against Talc Manufacturer
For mesothelioma patients, the path to justice is often hindered by legal complexities and roadblocks erected by asbestos companies. In the case of Craig Ludwig, talc supplier IMI Fabi LLC argued that they could not be sued in the state of New York. However, after review of the case, a New York Supreme Court judge
-
Mesothelioma Victims Challenge Court Ruling in Bestwall Bankruptcy Case
Many mesothelioma victims blame their illness on their use of products made by Georgia Pacific and its subsidiary Bestwall-Gypsum. Claims against the company have been stymied by the company’s attempts to use bankruptcy to evade liability for its negligence. Recently, claimants have asked the full Fourth Circuit Court to reconsider a ruling that allowed the
-
Libby’s CARD Clinic Continues Critical Mesothelioma Screening
Mesothelioma and other asbestos-related diseases continue to be urgent public health concerns in Libby, Montana, where the Center for Asbestos Related Disease (CARD) has provided essential clinical services since 2002. In June 2025, renowned physicians, scientists, and asbestos experts gathered in Libby for a screening, outreach, and education retreat. While there, they reaffirmed the critical
-
ADAO Celebrates 20th Annual Conference on the Eve of Mesothelioma Awareness Day
Today is Mesothelioma Awareness Day, and the Asbestos Disease Awareness Organization (ADAO) marked it by sending a letter to the U.S. Congress calling for swift passage of the bipartisan Alan Reinstein Ban Asbestos Now (ARBAN) Act of 2025. It also launched the Asbestos Action Navigator, the first mobile tool for asbestos prevention, exposure tracking, and care management. This
-
Doctor’s Long-awaited Mesothelioma Lawsuit Begins in Florida
Dr. Albert Casaretto died of pleural mesothelioma in 2022, after more than fifty years of using Johnson & Johnson’s talcum powder. His initial claim against the company and other defendants was entered in 2018, shortly after he was diagnosed with the rare and deadly disease, and scheduled for trial in 2020. Court closures due to
-
Louisiana Court Rules Against Shipyard in Mesothelioma Case
After his wife, Elaine, died from malignant mesothelioma, Joseph Raymond Steib, Sr., filed a lawsuit against Huntington Ingalls Incorporated, seeking justice and compensation for her death, which he believed was caused by asbestos exposure from his work at the Avondale Shipyards. When the company attempted to claim federal immunity protections and remove the case to
-
Boston Jury Awards $83 Million to Mesothelioma Victim
In what is believed to be the largest asbestos verdict ever awarded in the state of Massachusetts, a Boston jury has awarded a widower $83 million, including $60 million in punitive damages. Michael Lapointe’s lawsuit against American Art Clay Company accused the company’s asbestos-containing ceramics products of causing his wife, Judith’s, death, and called the
-
FDA Approval of New Solid Tumor Treatment Option Means More Choices for Mesothelioma Patients
The FDA’s recent approval of subcutaneous pembrolizumab (Keytruda Qlex) for solid tumors means that mesothelioma patients will have a more convenient treatment option available to them. Subcutaneous treatments can be administered quickly under the skin rather than through time-consuming intravenous infusions. The approval covers all types of solid tumor cancers for which intravenous pembrolizumab has
-
Talc Manufacturer’s Failure to Test Cited in Mesothelioma Argument
After Todd Hathaway died of malignant peritoneal mesothelioma, his widow, Fayda, filed a wrongful death claim against Avon Products, as well as Vi-Jon, LLC, the manufacturer behind multiple baby powder products Mr. Hathaway had used. Though the company filed a petition to have her case against them dismissed, the Supreme Court of Erie County allowed
-
Court Revives Widow’s Lung Cancer Worker’s Compensation Claim
Over a dozen former employees of Continental Tire diagnosed with mesothelioma and other asbestos-related diseases were given a new opportunity for justice when a North Carolina state appeals court agreed that the widow of a lung cancer victim could pursue a workers’ compensation claim despite the previous decision in a bellweather case. The decision gives
-
New Bipartisan Bill Aims to Prevent Future Mesothelioma Cases
Hoping to prevent future cases of malignant mesothelioma, a bipartisan group of senators and representatives has introduced comprehensive legislation to ban all forms of asbestos in America. The move represents a significant step toward protecting families from a substance that causes more than 40,000 deaths annually.
-
Australian Researchers Find Promising Targets for Mesothelioma Immunotherapy
Scientists from a famed research center in Australia have found a better way to harness the immune system to fight mesothelioma. Their analysis of the specific protein fragments that the rare form of cancer’s cells display on their surfaces could pave the way for more effective immunotherapy treatments.
